Otsuka Holdings stock
Price history
+47.89% over the period1 year: from ¥8,307.00 (November 18, 2025) to ¥12,285.00 (November 18, 2026), +47.89%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 18, 2026 | ¥12,285.00 |
| October 30, 2026 | ¥12,015.00 |
| September 30, 2026 | ¥11,585.00 |
| August 31, 2026 | ¥12,250.00 |
| July 31, 2026 | ¥11,100.00 |
| June 30, 2026 | ¥10,805.00 |
| May 29, 2026 | ¥11,715.00 |
| April 30, 2026 | ¥11,400.00 |
| March 31, 2026 | ¥11,010.00 |
| February 27, 2026 | ¥10,710.00 |
| January 30, 2026 | ¥9,241.00 |
| December 30, 2025 | ¥8,873.00 |
| November 28, 2025 | ¥8,846.00 |
| November 18, 2025 | ¥8,307.00 |
At a glance
The company
Diversified pharmaceutical, nutraceutical, consumer products and medical devices company with operations spanning psychiatry, oncology, diagnostics, food, beverages and specialized chemicals
Latest results
Quarter to September 30, 2026 · EPS ¥202.96 (estimate ¥185.55)
Dividend
TickerLandia's take on Otsuka Holdings
- Priced as usual relative to earnings: P/E on the latest fiscal year 18 vs a median of 19 over its last 10 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 17 vs 18 (−7%) in a group of 10.
- Strong point: Financial strength (87/100 in its group). Weak point: Dividend (20/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−3.99% from the 52-week high
Analysts · 13 analysts
Average target¥14,769.23+20.22% vs. price
Buy 10 · Hold 2 · Sell 1 · Buy
TickerLandia Fingerprint: Otsuka Holdings
Compared with similar companies: very high financial strength and very low risk.
Financials and price compared with 25 companies in the drug manufacturers - general industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.
Pricelow38
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 17.0 24 Forward P/E 24.0 81 EV/EBITDA 10.4 34 Price/book 2.03 23 Price/sales 2.43 30 Profitabilitylow30
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 71.9% 38 Net margin 14.4% 42 ROE 12.6% 31 ROA 7.3% 26 Operating margin 18.0% 14 Earnings stabilityhigh62
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 3.9% 70 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 54 Growthhigh61
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +11.30% 70 Earnings growth (year over year) −13.70% 27 Average revenue growth (3 years) +12.41% 86 Financial strengthvery high87
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −0.59 90 Current ratio 2.28 82 Interest coverage 99.1 86 Debt/equitycounts in reverse: lower means more financial strength 0.06 90 Dividendlow20
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 16 years 28 Payout ratio 23.2% 15 Dividend yield 1.6% 19 Market momentumstrong79
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +16.57% 79 Relative strength (6 months) +13.17% 72 1-year return +47.89% 86 Distance from 200-day average +10.01% 80 Riskvery low19
How much the price swings.
Metric Value Position in group Volatility (60 days) 32.1% 39 Beta (1 year) 0.13 13 Maximum drawdown (12 months) 14.2% 5
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Otsuka Holdings is priced as in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Otsuka Holdings's P/E today is 17.9, in line with the median of its last 10 fiscal years (19.4; between 13.0 and 29.8 from 2016 to 2025). Otsuka Holdings's P/E (trailing 12 months): 17.0, −7% against the median of a group of 10 similar companies (18.4).
Compared with 10 similar companies
| Metric | Otsuka Holdings | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 17.0 | Middle | |
| Forward P/E | 24.0 | High | |
| Operating margin | 18.0% | Low | |
| ROE | 12.6% | Middle | |
| Debt/equity | 0.06 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Otsuka Holdings. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥710.05B
Latest quarter · Q3 2026
Net income
¥106.49B
Latest quarter · Q3 2026
Quarterly net margin
15.0%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ¥6.53T
- P/E
- 17.0
- EPS
- ¥732.37
- Volume
- 1.17M
- Daily trading
- €86.9M
- Dividend yield
- 1.38%
How Otsuka Holdings is changing
All resultsRevenue grew 11.7% a year on average over the last 5 years
Operating margin rose from 9.7% to 17.0%
Profits turn into cash: free cash flow equal to 93% of net income
Returns
Otsuka Holdings returns with dividends
¥1,000 invested in Otsuka Holdings 5 years ago, on November 18, 2021, would be worth ¥3,273 today with dividends reinvested: +227.33% in total, +26.77% per year. On price alone it would be ¥2,971 (+197.10%).
| Period | Otsuka Holdings | Nikkei 225 | ¥1,000 becomes |
|---|---|---|---|
| 1 month | −0.28% | −9.15% | ¥997 |
| 6 months | +9.88% | −2.91% | ¥1,099 |
| Year to date | +38.45% | +17.16% | ¥1,385 |
| 1 year | +50.42% | +21.10% | ¥1,504 |
| 3 years | +136.81% | +76.65% | ¥2,368 |
| 5 years | +227.33% | +99.26% | ¥3,273 |
| 10 years | +220.84% | +228.25% | ¥3,208 |
Over the last 6 months it has done better than 48% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. Nikkei 225: price only. Calculate your investment
The chart in detail
Otsuka Holdings: technical analysis
Otsuka Holdings is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 3.3% below its all-time closing high (¥12,705.00, August 7, 2026).
- Trend
- Upward
- RSI (14 sessions)
- 54
- Between 30 and 70
- vs 200-session average
- +10.01%
Support and resistance
Price areas where Otsuka Holdings has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance¥12,690.00+3.30%5 touches, last on November 5, 2026
- Last price¥12,285.00
- Support¥11,900.00−3.13%3 touches, last on August 17, 2026
- Support¥11,503.75−6.36%4 touches, last on November 6, 2026
- Support¥10,792.14−12.15%7 touches, last on September 16, 2026
Volatility and risk
Over the last year it has moved little with the Nikkei 225.
- Beta (1 year) vs Nikkei 225
- 0.13
- Volatility (60 sessions, annualised)
- 32.1%
- Largest fall in the last year
- −14.17%
In session, November 18, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Otsuka Holdings: seasonality
Average monthly price change over 16 years
Over the last 16 years, the strongest month for Otsuka Holdings has been March: +3.18% on average, positive in 12 years out of 16. The weakest has been September: −1.01% on average, positive in 8 years out of 16. November, the current month, has been positive in 10 years out of 15 (+2.32% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.28% | +0.81% | 9 of 16 |
| February | +0.36% | −0.04% | 8 of 16 |
| March | +3.18% | +2.93% | 12 of 16 |
| April | +1.02% | +2.59% | 11 of 16 |
| May | +1.21% | +0.33% | 8 of 16 |
| June | +0.75% | +0.01% | 8 of 16 |
| July | +2.07% | +0.64% | 8 of 16 |
| August | +2.09% | +3.66% | 10 of 16 |
| September | −1.01% | +0.23% | 8 of 16 |
| October | +1.31% | +2.10% | 10 of 16 |
| November | +2.32% | +2.35% | 10 of 15 |
| December | −0.83% | +0.31% | 8 of 15 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Otsuka Holdings and its competitors
With 37,758 employees, Otsuka Holdings Co., Ltd. operates worldwide in pharmaceuticals, nutraceuticals and consumer products. Its drug portfolio spans psychiatry, neurology, oncology, cardiovascular and renal medicine, ophthalmology and diagnostics, alongside intravenous solutions and medical devices. The group also sells food and beverages, cosmetics, functional foods, chemical products and household goods, and offers clinical testing, IT solutions, equipment rental and logistics services. Its activities also include warehousing and transport, venture capital and incubation, and the manufacture of xenotransplantation products.
- Headquarters
- Chiyoda, Japan
- Employees
- 37,758
- Founded
- 1921
- Chief executive
- Makoto Inoue
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Otsuka Holdings4578 | $41.01B | 18.0% | 17.0 | +9.88% |
| Daiichi Sankyo4568 | $32.83B | 12.6% | 18.8 | +5.65% |
| Astellas Pharma4503 | $30.89B | 23.5% | 12.8 | +18.37% |
| Chugai Pharmaceutical4519 | $76.25B | 48.3% | 24.1 | −7.89% |
| CSPC Pharmaceutical Group1093 | $11.47B | 27.9% | 10.8 | +1.72% |
| BiogenBIIB | $37.07B | 23.5% | 107.2 | +29.98% |
Same industry or related industries, similar size. Compare Otsuka Holdings with its competitors · Full profile
